Allarity Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ALLR on Nasdaq
Location
24 School St., 2 Nd Floor, Boston, MA

There are no Buy or Sell transactions made by insiders since 10/25/2024

Allarity Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas Jensen Ceo $837K Jan 22, 2025
Alexander Epshinsky Cfo $179K Jan 22, 2025
Jeremy R. Graff President and Chief Development Officer $39.3K Sep 30, 2025
Gail J. Maderis Director Dec 20, 2021
Duncan Moore Director Dec 20, 2021
Marie Foegh Chief Medical Officer Dec 20, 2021
Soren Gade Jensen Director Dec 20, 2021
Steen Knudsen Chief Scientific Officer Dec 20, 2021
Leon Sass 10%+ Owner Dec 20, 2021
Joseph Vazzano Director Jan 22, 2025
Joan Brown Chief Financial Officer Jun 29, 2022
Gerald W. McLaughlin Director Jan 22, 2025
James Cullem SVP, Chief Business Officer Dec 20, 2021
Jens Erik Knudsen Former Chief Financial Officer Jun 27, 2022
Laura Benjamin Director Jan 22, 2025
Jeffrey S. Ervin Chief Financial Officer Jul 1, 2025
David Roth Director Jul 7, 2022
Steve Carchedi Chief Executive Officer, Director Dec 20, 2021

Recent Insider Transactions by Companies or Individuals for Allarity Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.